PB2305: EFGARTIGIMOD: CLINICAL DEVELOPMENT OF A NOVEL FCRN ANTAGONIST IN THE TREATMENT OF AUTOIMMUNE DISEASES

Saved in:
Bibliographic Details
Published inHemaSphere Vol. 6; no. Suppl; pp. 2175 - 2176
Main Authors Knoebl, P., Haard, H., Parys, W., Ulrichts, P., Rocca, F., Guglietta, A., Ayguasanosa, J.
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Lippincott Williams & Wilkins 23.06.2022
Wiley
Subjects
Publication Only
Online AccessGet full text

Cover

More Information
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000852048.36167.63